Safety and tolerability of yellow fever vaccines
| dc.contributor.author | Makhunga-Ramfolo, Nondumiso Siphosakhe | |
| dc.contributor.author | Rheeder, Paul | |
| dc.date.accessioned | 2012-05-23T08:29:41Z | |
| dc.date.available | 2012-05-23T08:29:41Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | Yellow fever is a non-contagious, viral, multisystem syndrome, that causes an estimated 200 000 human infections annually, and has a high fatality rate. Yellow fever vaccination is one of the main methods of primary prevention. Although the yellow fever vaccine is largely considered to be safe, adverse events, which are sometimes life-threatening, can occur. This article explores the safety and tolerability of yellow fever vaccines. | en_US |
| dc.description.uri | http://www.sajei.co.za/index.php/SAJEI | en_US |
| dc.identifier.citation | Makhunga-Ramfolo, NS & Rheeder, P 2011, 'Safety and tolerability of yellow fever vaccines', Southern African Journal of Epidemiology and Infection, vol. 27, no. 1, pp. 16-18. | en_US |
| dc.identifier.issn | 1015-8782 | |
| dc.identifier.uri | http://hdl.handle.net/2263/18837 | |
| dc.language.iso | en | en_US |
| dc.rights | © SAJEI | en_US |
| dc.subject | Yellow fever vaccination | en_US |
| dc.subject | Safety and tolerability | en_US |
| dc.title | Safety and tolerability of yellow fever vaccines | en_US |
| dc.type | Article | en_US |